RICCIARDI, GIUSEPPINA ROSARIA
RICCIARDI, GIUSEPPINA ROSARIA
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives
2015-01-01 Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria; Picone, Antonio; Ferraro, Giuseppa; Zanghì, Mariangela; Toscano, Giuseppe; Giordano, Antonio; Adamo, Vincenzo
Activity and safety of gefitinib and erlotinib in metastatic non-small cell lung cancer (NSCLC): A comparative analysis.
2010-01-01 Franchina, Tindara; Adamo, Barbara; Caristi, Nicola; G., Chiofalo; G., Toscano; Colonese, Francesca; Denaro, Nerina; Ricciardi, GIUSEPPINA ROSARIA; A., Russo; Adamo, Vincenzo; University, Polyclinic; Messina, Italy; School of, Medicine; University, Polyclinic; Palermo, Italy
Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: Two case reports.
2012-01-01 Franchina, Tindara; Adamo, Barbara; Ricciardi, GIUSEPPINA ROSARIA; Caristi, Nicola; Agostino, RITA MARIA; Proto, Claudia; Adamo, Vincenzo
Androgen Receptor (AR), E-Cadherin, and Ki-67 as emerging targets and novel prognostic markers in triple-negative breast cancer (TNBC) patients
2015-01-01 Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Ieni, Antonio; Licata, Luana; Cardia, Roberta; Ferraro, Giuseppa; Franchina, Tindara; Tuccari, Giovanni; Adamo, Vincenzo
Androgen receptor (AR), E-cadherin, and Ki-67 as prognostic markers in triple-negative breast cancer (TNBC).
2013-01-01 Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Ferraro, Giuseppa; Franchina, Tindara; Zanghi', Mariangela; Buda, Carmelo; Trimarchi, Giuseppe; Cardia, R; Tuccari, Giovanni; Adamo, Vincenzo
Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals
2023-01-01 Bisceglia, Irma; Canale, Maria Laura; Silvestris, Nicola; Gallucci, Giuseppina; Camerini, Andrea; Inno, Alessandro; Camilli, Massimiliano; Turazza, Fabio Maria; Russo, Giulia; Paccone, Andrea; Mistrulli, Raffaella; De Luca, Leonardo; Di Fusco, Stefania Angela; Tarantini, Luigi; Lucà, Fabiana; Oliva, Stefano; Moreo, Antonella; Maurea, Nicola; Quagliariello, Vincenzo; Ricciardi, Giuseppina Rosaria; Lestuzzi, Chiara; Fiscella, Damiana; Parrini, Iris; Racanelli, Vito; Russo, Antonio; Incorvaia, Lorena; Calabrò, Fabio; Curigliano, Giuseppe; Cinieri, Saverio; Gulizia, Michele Massimo; Gabrielli, Domenico; Oliva, Fabrizio; Colivicchi, Furio
Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer.
2014-01-01 Franchina T; Amodeo V; Bronte G; Savio G; Ricciardi GR; Picciotto M; Russo A; Giordano A; Adamo V.
Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients.
2012-01-01 Gangemi, Sebastiano; Minciullo, PAOLA LUCIA; Adamo, Barbara; Franchina, Tindara; Ricciardi, GIUSEPPINA ROSARIA; Ferraro, M; Briguglio, Roberta; Toscano, G; Saitta, Salvatore; Adamo, Vincenzo
Correlation between serum magnesium levels and skin toxicity during cetuximab treatment in squamous cell carcinoma of head and neck cancer (SCCHN): the role of weekly intravenous magnesium supplementation.
2013-01-01 Ferraro, Giuseppa; Proto, C; Del Re, C; Agostino, R; Zanghi', Mariangela; Buda, Carmelo; Ricciardi, GIUSEPPINA ROSARIA; Adamo, Vincenzo
Folate pathway implications in advanced Non Small Cell Lung Cancer (NSCLC): impact of thymidylate synthase (TS) promoter and methlylenetetrahydrofolate reductase (MTHFR) C677T and A1298C variants expression on patients’ outcome and correlation with p53 codon 72 mutations.
2011-01-01 Franchina, Tindara; Caristi, Nicola; Proto, Claudia; Chiofalo, G; Toscano, G; Ricciardi, GIUSEPPINA ROSARIA; Colonese, F; Caccamo, Daniela; Ientile, Riccardo; Adamo, Vincenzo
Induction chemotherapy with paclitaxel and cisplatin to concurrent radiotherapy and weekly paclitaxel in the treatment of loco-regionally advanced, stage IV (M0), head and neck squamous cell carcinoma. Mature results of a prospective study.
2011-01-01 Pergolizzi, Stefano; Anna, Santacaterina; Barbara, Adamo; Franchina, Tindara; Nerina, Denaro; Ferraro, Giuseppa; Ricciardi, GIUSEPPINA ROSARIA; Nicola, Settineri; Adamo, Vincenzo
Infra-centimetric HER2 positive Breast Cancer: The Southern Italy Experience.
2012-01-01 Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Caruso, M; Iacono, C; Blanco, G; Borsellino, N; Blasi, L; Bordonaro, R; Tuccari, Giovanni; Adamo, Vincenzo
Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes
2023-01-01 Franchina, M.; Pizzimenti, C.; Fiorentino, V.; Martini, M.; Ricciardi, G. R. R.; Silvestris, N.; Ieni, A.; Tuccari, G.
Management and treatment of triple-negative breast cancer patients from the NEMESI study: An Italian experience.
2012-01-01 Adamo, Vincenzo; Ricciardi, GIUSEPPINA ROSARIA; De Placido, S; Colucci, G; Conte, P; Giuffrida, D; Gebbia, N; Masci, G; Cognetti, F; Dondi, D; Venturini, M.
Multicenter study in women with infracentimetric HER2 positive breast cancer: The Regional Sicilian experience.
2012-01-01 Adamo, Vincenzo; Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Caruso, M; Soto Parra, H; Iacono, C; Prestifilippo, A; Gebbia, V; Lo Mauro, M; Saetta, A; Lavenia, G; Spadaro, P; Spinnato, F; Tuccari, Giovanni; on behalf AIOM SIAPEC Sicilian, Group
Observational study to evaluate the pattern of trastuzumab (T) use and survival outcomes in HER2-positive (HER2+) early breast cancer (EBC): Regional Southern Italy experience.
2011-01-01 Adamo, Vincenzo; Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; B., Agostara; M., Caruso; V., Gebbia; N., Gebbia; G., Lavenia; G. L., Banna; A., Mafodda; R., Rossello; A., Butera; S., Spada; N., Borsellino; A., Mangiameli; M., Campiglio; Tuccari, Giovanni; on behalf AIOM SIAPEC Sicilian, Group
Pegylated liposomal doxorubicin in combination with gemcitabine in elderly women with locally advanced or metastatic breast cancer: safety and activity results of our clinical experience.
2009-01-01 Adamo, Barbara; Franchina, Tindara; Denaro, Nerina; Garipoli, Claudia; Ferraro, Giuseppa; Briguglio, Roberta; Ricciardi, GIUSEPPINA ROSARIA; P., Gambadauro; G., Ferrandina; Adamo, Vincenzo
Pre-metastatic niche identification in node negative breast cancer to assess metastasis risk. Pathological and clinical implications.
2010-01-01 Adamo, V; Ieni, Antonio; Colonese, F; Adamo, Barbara; Ricciardi, GIUSEPPINA ROSARIA; Caristi, N; Ferraro, G; Garipoli, Claudia; Giuffrè, G; Tuccari, G.
Preliminary study of pre-metastatic niche (PMN) in nonmetastatic nodes for the assessment of metastasis risk in breast cancer (BC).
2009-01-01 Adamo, Vincenzo; Ieni, Antonio; Caristi, Nicola; Scarfi', Rosa; Barresi, Valeria; Giuffre', Giuseppe; Adamo, Barbara; Colonese, Francesca; Ferraro, Giuseppa; Ricciardi, GIUSEPPINA ROSARIA; Tuccari, Giovanni
Role of Androgen Receptor (AR), Ki 67 and E-cadherin as prognostic markers in Triple Negative Breast Cancer (TNBC)
2013-01-01 Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Cardia, R.; Ferraro, Giuseppa; Franchina, Tindara; Picciotto, Maria; Zanghi', Mariangela; Trimarchi, Giuseppe; Tuccari, Giovanni; Adamo, Vincenzo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives | 1-gen-2015 | Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria; Picone, Antonio; Ferraro, Giuseppa; Zanghì, Mariangela; Toscano, Giuseppe; Giordano, Antonio; Adamo, Vincenzo | |
| Activity and safety of gefitinib and erlotinib in metastatic non-small cell lung cancer (NSCLC): A comparative analysis. | 1-gen-2010 | Franchina, Tindara; Adamo, Barbara; Caristi, Nicola; G., Chiofalo; G., Toscano; Colonese, Francesca; Denaro, Nerina; Ricciardi, GIUSEPPINA ROSARIA; A., Russo; Adamo, Vincenzo; University, Polyclinic; Messina, Italy; School of, Medicine; University, Polyclinic; Palermo, Italy | |
| Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: Two case reports. | 1-gen-2012 | Franchina, Tindara; Adamo, Barbara; Ricciardi, GIUSEPPINA ROSARIA; Caristi, Nicola; Agostino, RITA MARIA; Proto, Claudia; Adamo, Vincenzo | |
| Androgen Receptor (AR), E-Cadherin, and Ki-67 as emerging targets and novel prognostic markers in triple-negative breast cancer (TNBC) patients | 1-gen-2015 | Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Ieni, Antonio; Licata, Luana; Cardia, Roberta; Ferraro, Giuseppa; Franchina, Tindara; Tuccari, Giovanni; Adamo, Vincenzo | |
| Androgen receptor (AR), E-cadherin, and Ki-67 as prognostic markers in triple-negative breast cancer (TNBC). | 1-gen-2013 | Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Ferraro, Giuseppa; Franchina, Tindara; Zanghi', Mariangela; Buda, Carmelo; Trimarchi, Giuseppe; Cardia, R; Tuccari, Giovanni; Adamo, Vincenzo | |
| Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals | 1-gen-2023 | Bisceglia, Irma; Canale, Maria Laura; Silvestris, Nicola; Gallucci, Giuseppina; Camerini, Andrea; Inno, Alessandro; Camilli, Massimiliano; Turazza, Fabio Maria; Russo, Giulia; Paccone, Andrea; Mistrulli, Raffaella; De Luca, Leonardo; Di Fusco, Stefania Angela; Tarantini, Luigi; Lucà, Fabiana; Oliva, Stefano; Moreo, Antonella; Maurea, Nicola; Quagliariello, Vincenzo; Ricciardi, Giuseppina Rosaria; Lestuzzi, Chiara; Fiscella, Damiana; Parrini, Iris; Racanelli, Vito; Russo, Antonio; Incorvaia, Lorena; Calabrò, Fabio; Curigliano, Giuseppe; Cinieri, Saverio; Gulizia, Michele Massimo; Gabrielli, Domenico; Oliva, Fabrizio; Colivicchi, Furio | |
| Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer. | 1-gen-2014 | Franchina T; Amodeo V; Bronte G; Savio G; Ricciardi GR; Picciotto M; Russo A; Giordano A; Adamo V. | |
| Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients. | 1-gen-2012 | Gangemi, Sebastiano; Minciullo, PAOLA LUCIA; Adamo, Barbara; Franchina, Tindara; Ricciardi, GIUSEPPINA ROSARIA; Ferraro, M; Briguglio, Roberta; Toscano, G; Saitta, Salvatore; Adamo, Vincenzo | |
| Correlation between serum magnesium levels and skin toxicity during cetuximab treatment in squamous cell carcinoma of head and neck cancer (SCCHN): the role of weekly intravenous magnesium supplementation. | 1-gen-2013 | Ferraro, Giuseppa; Proto, C; Del Re, C; Agostino, R; Zanghi', Mariangela; Buda, Carmelo; Ricciardi, GIUSEPPINA ROSARIA; Adamo, Vincenzo | |
| Folate pathway implications in advanced Non Small Cell Lung Cancer (NSCLC): impact of thymidylate synthase (TS) promoter and methlylenetetrahydrofolate reductase (MTHFR) C677T and A1298C variants expression on patients’ outcome and correlation with p53 codon 72 mutations. | 1-gen-2011 | Franchina, Tindara; Caristi, Nicola; Proto, Claudia; Chiofalo, G; Toscano, G; Ricciardi, GIUSEPPINA ROSARIA; Colonese, F; Caccamo, Daniela; Ientile, Riccardo; Adamo, Vincenzo | |
| Induction chemotherapy with paclitaxel and cisplatin to concurrent radiotherapy and weekly paclitaxel in the treatment of loco-regionally advanced, stage IV (M0), head and neck squamous cell carcinoma. Mature results of a prospective study. | 1-gen-2011 | Pergolizzi, Stefano; Anna, Santacaterina; Barbara, Adamo; Franchina, Tindara; Nerina, Denaro; Ferraro, Giuseppa; Ricciardi, GIUSEPPINA ROSARIA; Nicola, Settineri; Adamo, Vincenzo | |
| Infra-centimetric HER2 positive Breast Cancer: The Southern Italy Experience. | 1-gen-2012 | Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Caruso, M; Iacono, C; Blanco, G; Borsellino, N; Blasi, L; Bordonaro, R; Tuccari, Giovanni; Adamo, Vincenzo | |
| Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes | 1-gen-2023 | Franchina, M.; Pizzimenti, C.; Fiorentino, V.; Martini, M.; Ricciardi, G. R. R.; Silvestris, N.; Ieni, A.; Tuccari, G. | |
| Management and treatment of triple-negative breast cancer patients from the NEMESI study: An Italian experience. | 1-gen-2012 | Adamo, Vincenzo; Ricciardi, GIUSEPPINA ROSARIA; De Placido, S; Colucci, G; Conte, P; Giuffrida, D; Gebbia, N; Masci, G; Cognetti, F; Dondi, D; Venturini, M. | |
| Multicenter study in women with infracentimetric HER2 positive breast cancer: The Regional Sicilian experience. | 1-gen-2012 | Adamo, Vincenzo; Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Caruso, M; Soto Parra, H; Iacono, C; Prestifilippo, A; Gebbia, V; Lo Mauro, M; Saetta, A; Lavenia, G; Spadaro, P; Spinnato, F; Tuccari, Giovanni; on behalf AIOM SIAPEC Sicilian, Group | |
| Observational study to evaluate the pattern of trastuzumab (T) use and survival outcomes in HER2-positive (HER2+) early breast cancer (EBC): Regional Southern Italy experience. | 1-gen-2011 | Adamo, Vincenzo; Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; B., Agostara; M., Caruso; V., Gebbia; N., Gebbia; G., Lavenia; G. L., Banna; A., Mafodda; R., Rossello; A., Butera; S., Spada; N., Borsellino; A., Mangiameli; M., Campiglio; Tuccari, Giovanni; on behalf AIOM SIAPEC Sicilian, Group | |
| Pegylated liposomal doxorubicin in combination with gemcitabine in elderly women with locally advanced or metastatic breast cancer: safety and activity results of our clinical experience. | 1-gen-2009 | Adamo, Barbara; Franchina, Tindara; Denaro, Nerina; Garipoli, Claudia; Ferraro, Giuseppa; Briguglio, Roberta; Ricciardi, GIUSEPPINA ROSARIA; P., Gambadauro; G., Ferrandina; Adamo, Vincenzo | |
| Pre-metastatic niche identification in node negative breast cancer to assess metastasis risk. Pathological and clinical implications. | 1-gen-2010 | Adamo, V; Ieni, Antonio; Colonese, F; Adamo, Barbara; Ricciardi, GIUSEPPINA ROSARIA; Caristi, N; Ferraro, G; Garipoli, Claudia; Giuffrè, G; Tuccari, G. | |
| Preliminary study of pre-metastatic niche (PMN) in nonmetastatic nodes for the assessment of metastasis risk in breast cancer (BC). | 1-gen-2009 | Adamo, Vincenzo; Ieni, Antonio; Caristi, Nicola; Scarfi', Rosa; Barresi, Valeria; Giuffre', Giuseppe; Adamo, Barbara; Colonese, Francesca; Ferraro, Giuseppa; Ricciardi, GIUSEPPINA ROSARIA; Tuccari, Giovanni | |
| Role of Androgen Receptor (AR), Ki 67 and E-cadherin as prognostic markers in Triple Negative Breast Cancer (TNBC) | 1-gen-2013 | Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Cardia, R.; Ferraro, Giuseppa; Franchina, Tindara; Picciotto, Maria; Zanghi', Mariangela; Trimarchi, Giuseppe; Tuccari, Giovanni; Adamo, Vincenzo |